ShareValue scores for ALBERTDAVD.NSE: Valuation 70, Quality 35, Growth 21, Health 52.

ALBERTDAVD.NSE
NSE

Albert David Limited

₹737.50(+6.45%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

12% to 27%
Valuation
70
Undervalued
Price vs Value
Quality
35
Weak
Business Strength
Growth
21
Weak
Revenue & Earnings
Health
52
Moderate
Financial Stability
Momentum
48
Neutral
Price Trend

Company Details

About

Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs in India and internationally. It offers formulations for parenterals, oral/enterals, topical agents, aerosol, gynecology therapy, orthopedic, and vision care products. Albert David Limited was incorporated in 1938 and is headquartered in Kolkata, India.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026